Page 1,112«..1020..1,1111,1121,1131,114..1,1201,130..»

Surgical Procedures Volume Market Strong Development By Major Eminent Players, Technology And Forecasts To 2023 – BulletintheNews

Posted: Published on January 13th, 2020

A large number of companies are present in theglobal surgical procedures volume market, making it fragmented. Continue reading →

Posted in Interventional Cardiology | Comments Off on Surgical Procedures Volume Market Strong Development By Major Eminent Players, Technology And Forecasts To 2023 – BulletintheNews

Global Interventional Cardiology Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 – Primo Journal

Posted: Published on January 13th, 2020

Interventional Cardiology Market The global Interventional Cardiology market report includes a scrupulous analysis of the Interventional Cardiology market in the forecasted period. Continue reading →

Posted in Interventional Cardiology | Comments Off on Global Interventional Cardiology Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 – Primo Journal

Early Expressed Circulating Long Noncoding RNA CHAST is Associated with Cardiac Contractile Function in Patients with Acute Myocardial Infarction -…

Posted: Published on January 13th, 2020

BACKGROUND: The mortality rate during the acutemyocardial infarction(AMI) phase has substantially decreased, but post-AMI cardiac remodeling remains an important factor affecting patient prognosis. Continue reading →

Posted in Ventricular Remodeling | Comments Off on Early Expressed Circulating Long Noncoding RNA CHAST is Associated with Cardiac Contractile Function in Patients with Acute Myocardial Infarction -…

Atrial fibrillation in athletes – CMAJ

Posted: Published on January 13th, 2020

Too much exercise can cause atrial fibrillation Large observational studies have shown that a sedentary lifestyle increases the risk of atrial fibrillation fivefold.1,2 However, high-intensity aerobic exercise, especially for men, also increases the risk of atrial fibrillation at a threshold of more than 15002000 lifetime hours.3 Evidence is less clear for women.3 In the majority of athletes, atrial fibrillation is paroxysmal and symptomatic.2,3 High-intensity aerobic exercise causes increased hemodynamic stress and generates free radicals.4 The atria appear to be particularly susceptible, with resultant dilatation, chronic inflammation and fibrosis.24 Autonomic modulation also plays a role, and athletes commonly describe triggers that are vagally (sleep, meals) or adrenergically (exercise) mediated.2,3 It is important not to miss conditions associated with atrial fibrillation, including cardiomyopathies, channelopathies, pre-excitation, hyperthyroidism and alcohol or drug misuse.2,3 Energy supplements and performance enhancers should also be considered.2,3 Data on stroke risk among athletes are limited, but the use of thromboembolic risk scores (CHADS-65) is recommended.2,3,5 In nonrandomized studies, detraining has been shown to reduce atrial fibrillation, although athletes are often not willing to do this.2 Anti-arrhythmic medications are limited by bradycardia, impaired performance, long-term adverse effects and risk of ventricular arrhythmias during exercise.2,3 High-impact sports are a contraindication to anticoagulation.2,3 Data remain limited to small, nonrandomized studies, but ablation is often the preferred option for symptomatic athletes.2,3 Despite the distinct pathophysiology between symptomatic athletes and nonathletes, success rates appear similar to those of nonathletes: about 60% for the first procedure and > 80% for the second.2,3 Athletes not meeting CHADS-65 criteria must be informed of the need for anticoagulation for at least 2 months owing to the prothrombotic effect of catheter ablation.2,5 Continue reading →

Posted in Cardiomyopathies | Comments Off on Atrial fibrillation in athletes – CMAJ

Dyne Therapeutics Announces Appointment of Molly White as Vice President, Medical Communications and Advocacy – Yahoo Finance

Posted: Published on January 13th, 2020

Former chief executive officer of Myotonic brings extensive experience in patient advocacy and community engagement Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Molly White as Vice President, Medical Communications and Advocacy. Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Dyne Therapeutics Announces Appointment of Molly White as Vice President, Medical Communications and Advocacy – Yahoo Finance

Can this San Diego startup mimic exercise and fasting with a pill? Epirium raises $85M to find out – The San Diego Union-Tribune

Posted: Published on January 13th, 2020

A biotech startup in La Jolla has raised $85 million from notable science investors to investigate its idea for treating age-related diseases: a pill that mimics the effects of exercise and fasting. The company, called Epirium Bio, says its scientists have discovered a new human hormone, which, when influenced, can trigger the production of more mitochondria Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Can this San Diego startup mimic exercise and fasting with a pill? Epirium raises $85M to find out – The San Diego Union-Tribune

Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors – Yahoo Finance

Posted: Published on January 13th, 2020

CAMBRIDGE, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (SRPT), the leader in precision genetic medicine for rare diseases, announced that it has appointed John C Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors – Yahoo Finance

Inside Montel Williams’ journey from long-undiagnosed patient to MS activist – Media News – MM&M – Medical Marketing and Media

Posted: Published on January 13th, 2020

Given his level of education, the resources at his disposal and his media celebrity, one would place Montel Williams near the bottom of any list of individuals likely to endure a missed diagnosis for two full decades. And yet there he was during the bulk of the 1980s and 90s, enduring pain in his lower extremities and temporary blindness in one eye as doctor after doctor failed to diagnose him with relapsing-remitting multiple sclerosis. That he lived like this while, among other things, serving in the Navy, hosting a syndicated TV talk show and becoming a father to four children, ranks as a fairly amazing achievement in retrospect. Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Inside Montel Williams’ journey from long-undiagnosed patient to MS activist – Media News – MM&M – Medical Marketing and Media

Innovation in New Drug Approvals of 2019 Advances Patient Care – FDA.gov

Posted: Published on January 13th, 2020

By: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research Happy New Year! The beginning of a new year is always a rewarding time for the many dedicated staff at the FDA's Center for Drug Evaluation and Research (CDER) who work on approving new drug therapies. We look back over the past year and see how the work we did came together to help patients in need one of the main reasons why many of us, including me, have chosen a career in regulatory science and public health. Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Innovation in New Drug Approvals of 2019 Advances Patient Care – FDA.gov

Marketers: Focus on fundamentals to make a return this year – News – MM&M – Medical Marketing and Media

Posted: Published on January 13th, 2020

News stories from a certain Las Vegas electronics confab this week promise us all a future of health-oriented wearables and cyber companions. Among this years crop of gadgetry is a neuro-feedback headset designed to combat insomnia and a wristband that scans food and tells you what to eat based on your DNA. Make no mistake Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Marketers: Focus on fundamentals to make a return this year – News – MM&M – Medical Marketing and Media

Page 1,112«..1020..1,1111,1121,1131,114..1,1201,130..»